Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Microtest Diagnostics Appoints Group Managing Director

Published: Tuesday, June 12, 2012
Last Updated: Tuesday, June 12, 2012
Bookmark and Share
Appointment of former Phadia AB senior executive, Kjell Kristiansen as Group Managing Director.

Microtest Diagnostics has announced that it has appointed former Phadia AB senior executive, Kjell Kristiansen as Group Managing Director.

Mr. Kristiansen has worked within the medical diagnostic field for over 30 years, most notably with Sweden’s Pharmacia AB which subsequently became Phadia AB prior to its 2011 acquisition by Thermo Fisher for USD $3.5bn.

Mr. Kristiansen played a substantial role in the success of the business, having served in various posts including Regional Director for Asia, one of Phadia’s fastest growing divisions.

Prior to his 14 years in the post, Mr. Kristiansen held numerous positions both in business development within Pharmacia Diagnostics and as Managing Director for a number of companies within the Group.

Vito Levi D'Ancona, Executive Chairman said: "Kjell’s appointment comes at a significant point in the Company’s life as we prepare for the imminent launch of our ADAM™ testing platform and for driving growth in the Company thereafter. His track record in growing allergy and autoimmunity markets worldwide confirms his ability to help patients, doctors and laboratories better diagnose such diseases. We welcome him to the team."

ADAM™ is a CE-marked affordable diagnostic instrument, designed to be used by doctors, allergy and autoimmune disease specialists in-house, as well as for use in small labs.

ADAM™ offers a fully automated plug-and-play solution designed to be operated by non-technical personnel.

ADAM™ is based on a patented microarray technology that miniaturizes an assay of hundreds of proteins onto a single biochip. It simultaneously detects the levels of the antibody, IgE (an antibody created by the body’s immune system in response to allergy), with high precision and sensitivity using a few drops of blood.

The Company believes that the simplicity of the ADAM™ device will be valuable across multiple areas in the fast-growing field of allergy testing, particularly for children, given the small quantities of blood sample required and the ease and convenience with which the test can be administered directly by physicians at the time of patient visit.

Kjell Kristiansen said: “Allergy is a growing health problem around the world today. It affects the quality of life of around 30% of the population in the western world. The use of new multiplexing technology offers many advantages. I am looking forward to working with Microtest Diagnostics, and working towards physicians better diagnosing their patients in a fast, reliable and cost effective manner.”

The Company is currently scaling up production capabilities, signing agreements with key suppliers, and entering into distribution partnerships in several core territories as well as advancing regulatory approvals throughout the world.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Toxicity Testing With Cultured Liver Cells
Microreactor replaces animal testing.
Study Validates Analysis of Copy Number Variation in Miniaturized Reaction Volumes
Data shows that accurate and reproducible CNV results can be produced with IntelliQube using the Array Tape® consumable.
Organs on Chips
Combining 3D cell culture with microfluidics, organs-on-chips could revolutionize toxicology testing for pharmaceuticals, foods, cosmetics, pesticides, and industrial chemicals.
Finding the Needle in a Microbial Haystack
After developing a novel investigational technology called PathoChip that can rapidly identify elusive microorganisms, a team of Penn Medicine researchers recently succeeded for the first time in identifying a pathogen in a patient sample, demonstrating the proof of principle that this technology can be used to identify pathogens in human disease.
Organ-on-a-Chip
In a step toward personalized drug testing, researchers coax human stem cells to form complex tissues.
Diagnosing Cancer from a Single Drop of Blood
What if a physician could effectively diagnose cancer from one drop of a patient’s blood?
Study Reveals Shared Behavior of Microbes And Electrons
Bacteria streaming through a lattice behave like electrons in a magnetic material.
Study Reveals Shared Behavior of Microbes and Electrons
Bacteria streaming through a lattice behave like electrons in a magnetic material.
Detecting When and Why Deadly Blood Clots Form
New bioinspired blood coagulation assay is more sensitive than existing assays and could one day be used to diagnose rare bleeding disorders and prevent toxic effects of anticoagulant and antiplatelet drugs.
Tracing a Cellular Family Tree
New technique allows tracking of gene expression over generations of cells as they specialize.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!